DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024
DaVita Clinical Research (DCR) will present five research projects at ASN's Kidney Week 2024 in San Diego. The research focuses on improving racial equity in transplantation and clinical quality measures. Studies examine topics including: the impact of nephrologist visits on hospitalization rates, racial disparities in transplant processes among Hispanic dialysis patients, effects of heavy precipitation on dialysis treatment attendance, early indicators of ESKD transition in AKI-dialysis patients, and blood pressure thresholds in CKD patients. The presentations aim to enhance upstream CKD care management and promote health equity.
DaVita Clinical Research (DCR) presenterà cinque progetti di ricerca alla Kidney Week 2024 dell'ASN a San Diego. La ricerca si concentra su migliorare l'equità razziale nei trapianti e le misure di qualità clinica. Gli studi esaminano argomenti tra cui: l'impatto delle visite ai nefrologi sulle tassi di ospedalizzazione, le disparità razziali nei processi di trapianto tra i pazienti ispanici in dialisi, gli effetti di forti precipitazioni sulla frequenza di trattamento in dialisi, gli indicatori precoci di transizione all'ESKD nei pazienti in dialisi dopo AKI, e le soglie di pressione sanguigna nei pazienti con CKD. Le presentazioni mirano a migliorare la gestione dell'assistenza CKD e a promuovere l'equità sanitaria.
DaVita Clinical Research (DCR) presentará cinco proyectos de investigación en la Kidney Week 2024 de ASN en San Diego. La investigación se centra en mejorar la equidad racial en los trasplantes y las medidas de calidad clínica. Los estudios examinan temas que incluyen: el impacto de las visitas a nefrólogos en las tasas de hospitalización, disparidades raciales en los procesos de trasplante entre pacientes hispanos en diálisis, efectos de precipitaciones intensas en la asistencia al tratamiento de diálisis, indicadores tempranos de transición a ESKD en pacientes de diálisis después de AKI y umbrales de presión arterial en pacientes con CKD. Las presentaciones tienen como objetivo mejorar la gestión del cuidado de la CKD y promover la equidad en salud.
DaVita Clinical Research (DCR)은 샌디에이고에서 열리는 ASN의 Kidney Week 2024에서 다섯 개의 연구 프로젝트를 발표할 예정입니다. 연구는 이식에서 인종적 형평성 향상과 임상 품질 지표 개선에 초점을 맞추고 있습니다. 연구는 다음과 같은 주제를 조사합니다: 신장 전문의 방문이 입원율에 미치는 영향, 히스패닉 투석 환자들 사이의 이식 과정에서의 인종적 불균형, 강수량이 투석 치료 참석에 미치는 영향, AKI-투석 환자에서 ESKD로의 전환을 위한 조기 지표, CKD 환자의 혈압 기준입니다. 발표는 CKD 관리의 개선과 건강 형평성 증진을 목표로 합니다.
DaVita Clinical Research (DCR) présentera cinq projets de recherche lors de la Kidney Week 2024 de l'ASN à San Diego. La recherche se concentre sur l'amélioration de l'équité raciale dans les transplantations et les mesures de qualité clinique. Les études examinent des sujets tels que : l'impact des visites chez le néphrologue sur les taux d'hospitalisation, les disparités raciales dans les processus de transplantation parmi les patients hispaniques en dialyse, les effets des fortes précipitations sur la fréquentation des traitements de dialyse, les indicateurs précoces de transition vers l'ESKD chez les patients en dialyse après un AKI, et les seuils de pression artérielle chez les patients atteints de CKD. Les présentations visent à améliorer la gestion des soins CKD et à promouvoir l'équité en santé.
DaVita Clinical Research (DCR) wird auf der Kidney Week 2024 der ASN in San Diego fünf Forschungsprojekte vorstellen. Die Forschung konzentriert sich auf die Verbesserung der Rassen-Gleichheit bei Transplantationen und die klinischen Qualitätsmaßnahmen. Die Studien untersuchen unter anderem: die Auswirkungen von Nephrologenbesuchen auf die Krankenhausaufenthaltsraten, rassische Ungleichheiten im Transplantationsprozess bei hispanischen Dialysepatienten, die Auswirkungen von starkem Niederschlag auf die Teilnahme an Dialysebehandlungen, frühe Indikatoren für den Übergang zu ESKD bei AKI-Dialysepatienten und Blutdruckgrenzwerte bei CKD-Patienten. Die Präsentationen haben zum Ziel, das Management der CKD-Versorgung zu verbessern und die Gesundheitsgerechtigkeit zu fördern.
- Research initiatives demonstrate company's commitment to improving clinical outcomes
- Focus on addressing racial disparities could lead to market expansion in underserved populations
- Multiple research studies targeting key areas of kidney care management indicate strong R&D pipeline
- None.
The poster presentations include:
- Nephrologist Visits Lower Rates of Hospitalization, Mortality, and ESKD Transition in CKD Patients
Authors: Steph Karpinski, Michael O'Shea, Steven M. Brunelli - Racial Disparities Exist in the Transplant Process among Hispanic Patients on Dialysis
Authors: Adam G. Walker, Carey Colson, Danelle Radney, Unini Odama, Will Maixner, Francesca Tentori, Steven M. Brunelli - Association of Heavy Precipitation with the In-Center Dialysis Treatment Absenteeism
Authors: Adam G. Walker, Carey Colson, Scott Sibbel, Mesbah Ahmad, Francesca Tentori, Steven M. Brunelli - Early Clinical Indicators of ESKD Transition or Renal Recovery in AKI-Dialysis Patients
Authors: Scott Sibbel, Claire Ryan, Carey Colson, Cicely Gibson, Irina Goykhman, Francesca Tentori, Steven Brunelli - Systolic Blood Pressure Threshold and Clinical Outcomes in CKD 4/5 Patients
Authors: Jiacong Luo, Claire Ryan, Scott Sibbel, Carey Colson, Gilbert Marlowe, Michael O'Shea, Francesca Tentori, Steven M. Brunelli
"Kidney Week offers a unique opportunity to share groundbreaking research and foster meaningful dialogue within the nephrology community," stated Dr. Brunelli, vice president of health analytics and insights at DaVita. "Our findings support our unwavering commitment to enhancing upstream CKD care management, preventing kidney failure and promoting health equity. We look forward to engaging with attendees on these critical issues as DaVita strives to make a positive impact for patients."
ASN Kidney Week attendees can visit booth #821 at the
Throughout the event, DaVita will share highlights and updates on social media. Follow @DaVitaDoc on X to learn more and engage with content from the meeting.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly-owned subsidiary of DaVita Inc., is the research arm of DaVita. DCR innovates through retrospective research aimed at improving clinical outcomes. DCR assists pharmaceutical and medical device companies in the design, recruitment and completion of clinical trials using its renal research site network. To learn more about DCR, visit DaVitaClinicalResearch.com.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Media Contact:
DaVita Newsroom
newsroom@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-research-centers-on-upstream-ckd-management-access--equity-during-asns-kidney-week-2024-302283815.html
SOURCE DaVita
FAQ
What research is DaVita (DVA) presenting at ASN Kidney Week 2024?
How is DaVita (DVA) addressing racial disparities in kidney care?
What are the main clinical quality measures being studied by DaVita (DVA) in 2024?
